| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/25/2003 | CA2409552A1 Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract |
| 04/24/2003 | WO2003034275A2 Chimeric glycosylphosphatidylinositol containing peptides |
| 04/24/2003 | WO2003033720A2 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 04/24/2003 | WO2003033681A2 Composition comprising a lactobacillus pentosus strain and uses thereof |
| 04/24/2003 | WO2003033657A2 Antisense antiviral agent and method for treating ssrna viral infection |
| 04/24/2003 | WO2003033653A2 Affinity enhancement agents |
| 04/24/2003 | WO2003033596A1 Anti-bacterial composite particles and anti-bacterial resin composition |
| 04/24/2003 | WO2003033532A1 Anitmicrobial proteins, genes encoding the proteins and mehtod of using the same |
| 04/24/2003 | WO2003033528A1 Cyclic peptides as g-protein-coupled receptor antagonists |
| 04/24/2003 | WO2003033527A2 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 04/24/2003 | WO2003033502A1 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/24/2003 | WO2003033499A2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 04/24/2003 | WO2003033496A1 Beta-carbolin derivatives as ptp-inhibitors |
| 04/24/2003 | WO2003033483A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 04/24/2003 | WO2003033482A1 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003033466A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 04/24/2003 | WO2003033457A1 Biphenyl-derivatives as p38-kinase inhibitors |
| 04/24/2003 | WO2003033031A1 Dosage form, device and methods of treatment |
| 04/24/2003 | WO2003033029A1 Replication competent dual-ad vectors for vaccine and immunotherapy applications |
| 04/24/2003 | WO2003033021A1 Use of peptide vectors to improve the immune response to antigens |
| 04/24/2003 | WO2003033010A1 Cyclosporin analogs for the treatment of autoimmune diseases |
| 04/24/2003 | WO2003032997A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 04/24/2003 | WO2003032993A1 Use of phosphorodiesterase iv inhibitors |
| 04/24/2003 | WO2003032989A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 04/24/2003 | WO2003032987A1 2'-methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032986A1 2' -methyl-5-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032985A2 Concomitant oral and topical administration of anti - infective agents |
| 04/24/2003 | WO2003032982A1 Bis-heteroaryl alkanes as therapeutic agents |
| 04/24/2003 | WO2003032981A1 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 04/24/2003 | WO2003032980A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032973A2 Composition comprising paracetamol and a bitterness masking component |
| 04/24/2003 | WO2003032972A1 5’-carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032971A1 5’-acylamino-1,1’-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032970A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032964A2 Gap junctions and endothelial-derived hyperpolarizing factor (edhf) |
| 04/24/2003 | WO2003032962A2 Dual action antibiotics |
| 04/24/2003 | WO2003032958A1 Use of a copolymer to produce a galenic form containing a peptide or a protein as active agent |
| 04/24/2003 | WO2003032955A1 Highly compressible ethylcellulose for tableting |
| 04/24/2003 | WO2003032948A2 Compositions and methods for delivering antibacterial, antifungal and antiviral ointments to the oral, nasal or vaginal cavity |
| 04/24/2003 | WO2003032944A1 Anti-microbial composition comprising a metal ion chelating agent |
| 04/24/2003 | WO2003032928A2 Therapeutic composition and use |
| 04/24/2003 | WO2003032920A2 Oligonucleotide modulation of cell adhesion |
| 04/24/2003 | WO2003032918A2 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 04/24/2003 | WO2003032911A2 Anti-angiogenic and cytotoxic fused pyrimidines |
| 04/24/2003 | WO2003032910A2 Carbinols for the treatment of neuropathic dysfunction |
| 04/24/2003 | WO2003032905A2 Preparation and use of carbohydrate-based ring structures with antimicrobial and cytostatic activity |
| 04/24/2003 | WO2003032904A2 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi) |
| 04/24/2003 | WO2003032898A2 Modified human thymic stromal lymphopoietin |
| 04/24/2003 | WO2003032753A1 Use of cystathionine |
| 04/24/2003 | WO2003018608A8 Process for purifying glycopeptide phosphonate derivatives |
| 04/24/2003 | WO2003004049A3 Use of polyclonal anti-hiv goat serum as a therapeutic agent |
| 04/24/2003 | WO2002100437A3 Ophthalmic compositions comprising hyaluronic acid |
| 04/24/2003 | WO2002097072A3 Influenza vaccine composition |
| 04/24/2003 | WO2002088343A3 RECOMBINANT EXPRESSION OF hHBV REVERSE TRANSCRIPTASE (RT) |
| 04/24/2003 | WO2002087614A3 Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen |
| 04/24/2003 | WO2002085848A3 Synthesis of pancratistatin prodrugs |
| 04/24/2003 | WO2002085295A3 Methods and compositions for the modulation of biofilm formation |
| 04/24/2003 | WO2002079397A3 Virus derived antimicrobial peptides |
| 04/24/2003 | WO2002079147A3 Inhibitors of prenyl-protein transferase |
| 04/24/2003 | WO2002069979A3 Pharmaceutical formulation comprising r-salmeterol and fluticasone propionate |
| 04/24/2003 | WO2002068406A3 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 04/24/2003 | WO2002066018A3 Transdermal therapeutic system containing testosterone and method for the production thereof |
| 04/24/2003 | WO2002065129A3 Epitopic sequences for diagnosing infection by chlamydia trachomatis |
| 04/24/2003 | WO2002064748A8 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 04/24/2003 | WO2002064154A3 Methods and compositions for inhibiting hiv-coreceptor interactions |
| 04/24/2003 | WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors |
| 04/24/2003 | WO2002050120A3 High affinity antibodies |
| 04/24/2003 | WO2002046383A3 Protein modification and maintenance molecules |
| 04/24/2003 | WO2002043786B1 Uses for medical devices having a lubricious, nitric oxide-releasing coating for the therapy of vascular disorders |
| 04/24/2003 | WO2002031498A3 Protecting therapeutic compositions from host-mediated inactivation |
| 04/24/2003 | WO2002026825A3 G-protein coupled receptors |
| 04/24/2003 | WO2002024180A3 Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia |
| 04/24/2003 | WO2002018585A8 Packaging of positive-strand rna virus replicon particles |
| 04/24/2003 | WO2002016615A3 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase |
| 04/24/2003 | WO2001080856A3 Use of anethole-dithiolethione for preventing and treating drug-induced tendon toxicity |
| 04/24/2003 | US20030078418 Useful potentiators of beta -lactam antibiotics; therapy |
| 04/24/2003 | US20030078410 Expression vector for use in the transfer of genes and preparation of vaccines |
| 04/24/2003 | US20030078299 Anti-cancer nitro- and thia-fatty acids |
| 04/24/2003 | US20030078280 Macroheterocylic compounds useful as kinase inhibitors |
| 04/24/2003 | US20030078275 For therapy of cancer, diabetes and Alzheimer's disease |
| 04/24/2003 | US20030078270 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 04/24/2003 | US20030078241 Treating effects of excessive reactive oxygen species |
| 04/24/2003 | US20030078239 Ketone compounds and compositions for cholesterol management and related uses |
| 04/24/2003 | US20030078212 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same |
| 04/24/2003 | US20030078209 Porous composition, substantially insoluble in water, comprising 25% by weight oxidised cellulose and exhibiting a significant capacity to remove iron from aqueous environment; treatment of infections by iron-requiring microorganisms |
| 04/24/2003 | US20030078189 Medicinal compositions for oral use |
| 04/24/2003 | US20030078166 Pyrazole compounds useful as protein kinase inhibitors |
| 04/24/2003 | US20030077826 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC) |
| 04/24/2003 | US20030077802 Human PRL1 phosphatase |
| 04/24/2003 | US20030077749 Ucp5 |
| 04/24/2003 | US20030077734 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
| 04/24/2003 | US20030077694 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory disorders |
| 04/24/2003 | US20030077638 MID 4460, a human tyrosine phosphatase family member and uses therefor |
| 04/24/2003 | US20030077585 Nucleotide sequences coding polypeptide for use in the diagnosis, detection, prevention and treatment of bacterial infection |
| 04/24/2003 | US20030077579 Diagnostic assay |
| 04/24/2003 | US20030077578 Diagnostic assay |
| 04/24/2003 | US20030077565 Preservation of corneal graft in vitro; obtain graft, incubate with antisense oligonucleotides in solution, monitor viability of graft tissue |
| 04/24/2003 | US20030077327 Highly compressible ethylcellulose for tableting |
| 04/24/2003 | US20030077325 Mixture of drug and hydrophilic polymer; water solubility |
| 04/24/2003 | US20030077301 Topically administering to a localized region affected by the inflammatory dermatosis on a patient skin a formulation containing a active agent,and a permeation enhancing base to enhance the flux of active agent through skin without damage |